Molecule
Tirzepatide
Approved product exists
An FDA-approved tirzepatide product exists. The register holds 481 single-ingredient programs, 191 with a comparable monthly price, plus 2 combined programs containing tirzepatide. Combined program totals are excluded from single-ingredient prices. Classification recorded August 2026.
Forms
- Brand tirzepatide101 entries$299 to $1,999 per month
- Compounded tirzepatide374 entries$69 to $660 per month
- Tirzepatide · formulation not established6 entries
Programs with formulation not established
More columns to the right? Scroll across the table to see all details.
| Entry | Provider | Form | Recorded price with its payment basis | Last verified | Link |
|---|---|---|---|---|---|
| EntryTR-0423 | ProviderAbundRX | FormNot recorded | Recorded price$149 Published figure · Tirzepatide-based care starting figure; billing period unknown Initial payment not verified Recurring price conditions not established Prescription and individual eligibility required. This published figure does not establish a full payable invoice, payment interval or automatic renewal. | Last verifiedOctober 2026 | Record |
| EntryTR-0492 | ProviderDoctorAdam | FormOral tablet | Recorded price$199 Published figure · Advertised monthly starting program; invoice unverified Initial payment not verified Recurring price conditions not established Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established. | Last verifiedOctober 2026 | Record |
| EntryTR-0494 | ProviderDoctorAdam | FormInjection · device not recorded | Recorded price$229 Published figure · Advertised monthly starting program; invoice unverified Initial payment not verified Recurring price conditions not established Prescription and individual clinical eligibility required. Starting advertisement; selected dose and final invoice are not established. | Last verifiedOctober 2026 | Record |
| EntryTR-0533 | ProviderHealth Source Online | FormInjection · device not recorded | Recorded price$299 Published figure · Full Dose; displayed recurring charge Initial payment not verified Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. | Last verifiedOctober 2026 | Record |
| EntryTR-0534 | ProviderHealth Source Online | FormSublingual | Recorded price$399 Published figure · Full Dose; displayed recurring charge Initial payment not verified Public supply selector price; exact dose, medication-inclusion scope and final checkout invoice are unverified. Supply-label weeks are not substituted for the displayed billing period. | Last verifiedOctober 2026 | Record |
| EntryTR-1059 | ProviderHormonally Balanced | FormInjection · device not recorded | Recorded price$475 Published figure · Published monthly program; payment unverified Initial payment not verified Recurring price conditions not established | Last verifiedOctober 2026 | Record |
Combined programs containing tirzepatide
These are whole-program records. Their totals do not price this ingredient separately.
A compounded preparation is not itself an FDA-approved product, so each form is recorded and priced separately rather than rolled together.